Warning: The NCBI web site requires JavaScript to function. more...
An official website of the United States government
The .gov means it's official. Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you're on a federal government site.
The site is secure. The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.
CD44 - Multiple myeloma cell lines with acquired resistance to chemotherapeutic agent carfilzomib
GEO DataSets Gene Profile neighbors Chromosome neighbors Homologene neighbors
ZNF155 - Multiple myeloma cell lines with acquired resistance to chemotherapeutic agent carfilzomib
GEO DataSets Gene Profile neighbors Chromosome neighbors
HCFC2 - Multiple myeloma cell lines with acquired resistance to chemotherapeutic agent carfilzomib
BUB3 - Multiple myeloma cell lines with acquired resistance to chemotherapeutic agent carfilzomib
NDUFB10 - Multiple myeloma cell lines with acquired resistance to chemotherapeutic agent carfilzomib
UBA52 - Multiple myeloma cell lines with acquired resistance to chemotherapeutic agent carfilzomib
MRPL42 - Multiple myeloma cell lines with acquired resistance to chemotherapeutic agent carfilzomib
GFM1 - Multiple myeloma cell lines with acquired resistance to chemotherapeutic agent carfilzomib
PPP3CB - Multiple myeloma cell lines with acquired resistance to chemotherapeutic agent carfilzomib
TAF5 - Multiple myeloma cell lines with acquired resistance to chemotherapeutic agent carfilzomib
MED17 - Multiple myeloma cell lines with acquired resistance to chemotherapeutic agent carfilzomib
CASC7 - Multiple myeloma cell lines with acquired resistance to chemotherapeutic agent carfilzomib
PUS1 - Multiple myeloma cell lines with acquired resistance to chemotherapeutic agent carfilzomib
UTP23 - Multiple myeloma cell lines with acquired resistance to chemotherapeutic agent carfilzomib
FAM69A - Multiple myeloma cell lines with acquired resistance to chemotherapeutic agent carfilzomib
RPL5 - Multiple myeloma cell lines with acquired resistance to chemotherapeutic agent carfilzomib
NUP98 - Multiple myeloma cell lines with acquired resistance to chemotherapeutic agent carfilzomib
Filters: Manage Filters
Your browsing activity is empty.
Activity recording is turned off.
Turn recording back on